Addus HomeCare (ADUS) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
13 May, 2026Volume and operational trends
Sequential census growth observed from February to March, with positive momentum continuing into Q2 across key markets.
Illinois, New Mexico, and Texas all showed census improvement, with Illinois highlighted for starts of care exceeding discharges.
Weather disruptions in January impacted volumes, particularly in Texas, but recovery followed in subsequent months.
Hours per consumer grew by 2.2% in Q1, aligning with targeted growth rates.
Technology adoption, specifically a caregiver app, contributed to improved utilization and operational efficiency.
Technology and efficiency initiatives
The caregiver app increased billable hour utilization rates from low 80s to high 80s in Illinois over 12–18 months.
App deployment expanded to Texas and New Mexico, with early uptake indicating future benefits.
Key benefits include caregivers tracking available hours, self-scheduling, and reducing missed visits.
Office staff efficiency improved as caregivers handle more scheduling independently.
The app supports a strategic shift toward balanced organic growth between volume and rate.
Market positioning and payer relationships
Increased market density and compliance reputation enhance attractiveness to payers, supporting preferred provider status.
Recent acquisitions, such as Gentiva, expanded presence in Texas and improved relationships with major payers.
Balanced growth between rate and volume is being achieved, with Q4 showing near 50/50 split.
Ongoing focus on compliance and technology positions the company favorably amid industry scrutiny.
Latest events from Addus HomeCare
- Q1 2026 revenue up 7.7%, net income up 18.1%, driven by personal care and hospice growth.ADUS
Q1 20265 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ADUS
Proxy filing23 Apr 2026 - Achieved $1.4B revenue in 2025 with strong growth, stable margins, and expanding national footprint.ADUS
Investor presentation23 Apr 2026 - Hospice recovery, census growth, and tech-driven hiring fuel expansion amid stable rates.ADUS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong Q4 exit, tech-driven efficiency, and robust growth outlook amid regulatory changes.ADUS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Margins, growth, and M&A drive performance as census rebounds and tech boosts fill rates.ADUS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 2025 revenue and EBITDA surged, led by personal care and hospice growth.ADUS
Q4 202524 Feb 2026 - Growth driven by acquisitions, tech, and value-based care, with census recovery expected by 2026.ADUS
Jefferies 2025 Healthcare Services Conference3 Feb 2026 - Q2 revenue up 10.4%, net income $18.1M, major equity raise, Gentiva deal, NY divestiture.ADUS
Q2 20242 Feb 2026